Kimberly Dormer

Kimberly Dormer serves as a Contracting Officer at the National Institutes of Health, where she plays a pivotal role in advancing biomedical research through strategic acquisition of high-precision scientific instruments, biotechnology reagents, and specialized computational services. She manages complex procurements aligned with the NIH’s mission to enable cutting-edge life sciences research, ensuring compliance with federal acquisition regulations while supporting hypothesis-driven discovery and clinical translation. Her portfolio primarily encompasses research and development contracts requiring technical rigor, regulatory adherence, and rapid deployment of mission-critical capabilities across NIH institutes and laboratories. Dormer maintains longstanding partnerships with key contractors including LEIDOS BIOMEDICAL RESEARCH INC, KELLY SERVICES, INC., FORS MARSH GROUP LLC, PPD DEVELOPMENT LP, and WHITING-TURNER CONTRACTING COMPANY, THE. These relationships reflect a balanced approach between large, specialized firms with deep scientific infrastructure and service providers capable of delivering high-compliance technical support, clinical trial logistics, and facility modernization. Her contracting patterns emphasize performance-based outcomes, risk mitigation in sensitive research environments, and rigorous vendor evaluation for technical capability and data integrity. Her procurement strategy prioritizes total small business set-asides under FAR 19.5, with 37.5% of awards reserved for small businesses, demonstrating a strong commitment to socioeconomic diversity in the scientific supply chain. While the majority of acquisitions are unrestricted, she actively leverages small business capabilities to foster innovation and broaden vendor participation in life sciences contracting. Dormer’s primary focus lies in NAICS 541714 (Biotechnology R&D) and 541715 (Life Sciences R&D), where she procures advanced laboratory instrumentation, bioinformatics software, assay development services, and specialized research support. Her expertise spans the full lifecycle of scientific acquisitions—from needs assessment and market research to contract award and performance management—ensuring that NIH’s research ecosystem is equipped with the most capable, compliant, and technologically advanced resources available.